C4 therapeutics inc.

Other-Pharmaceuticals

CCCC


490 Arsenal Way
Watertown , MA 02472

Executive/
Director

Price

  • Last Close
  • $ 4.41
    $ +0.5 12.8 %
    Dec 6, 2024
  • 52-Week High/Low
  • $11 - $1.18
  • YTD
  • -22%

  • Trading Volume
  • 52,496
  • Market Cap Full
  • $ 216.4M
  • Shares Outstanding
  • 49.1M
    Apr 25, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% 6.2% -27.8% -46.8% 44.6%
Q2 - - - - - 4% 2.3% -68.9% -12.4% -5.2%
Q3 - - - - - 8% 18.3% 16.3% -32.4% -
Q4 - - - - - 36.6% -24.9% -32.7% 232.4% -
J F M A M J J A S O N D
2024 9.4% 77.7% -25.6% -6% - - - - - - - -
2023 32% -32.4% -40.4% -3.8% 12.3% -18.9% 41.5% -25.5% -35.9% -19.9% 9.4% 246.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%-3%-82%-4%-22%

Earnings

2021 2022 2023
Q1 -0.49 -0.65 -0.71
Q2 -0.51 -0.56 -0.73
Q3 -0.51 -0.65 -0.55
Q4 -0.31 -0.76 -
A -1.8 -2.6 -1.99

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 43.1 48.7 49.1
Jun - 43.2 48.8 49.1
Sep - 48.5 48.9 -
Dec 43 48.6 49 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.4 0.3 5.5 3 -
Total Asset Turnover 0.1 0.1 0.1 0.2 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 65 -41 -10 35 -
Equity multiplier 0.3 0.4 - -7 -